INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 45h ago
HOUSE PTR5h ago
SEC 13F5h ago
ROBINHOOD CHAIN5h ago
SEC FORM 4/Grant or awardVerified data

Anderson Dyaarl Lee Jr. reported SERA

Chief Commercial Officer · SERA PROGNOSTICS, INC. · Class A Common Stock

Side
A
Value
$5,829
Shares
3,168
Price
$1.84
Executed
May 29, 2026
Disclosed
Jun 1, 2026
Disclosure timeline3 days from execution to publication · legal deadline 2 business days
May 29 executedJun 1, 2026 disclosed

SERA · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
9/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+1 / 25

$6K reported value · 4.0% of prior position

  • Filing timing0 / 15

    Disclosed 1 business day after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · SERA

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    21
    ID
    Inglis Tiffany Eul DavisChief Medical Officer
    SERASERA PROGNOSTICS, INC.
    Open-market sale
    		SELL$16K
    8,024 sh
    		Oct 12, 2026Oct 13, 2026
    traded Oct 12, 2026
    		+1dSEC FORM 4

    Evidence

    32
    ID
    Inglis Tiffany Eul DavisChief Medical Officer
    SERASERA PROGNOSTICS, INC.
    Open-market sale
    		SELL$972
    486 sh
    		Sep 10, 2026Sep 11, 2026
    traded Sep 10, 2026
    		+1dSEC FORM 4

    Evidence

    32
    LZ
    Lindgardt ZhenyaDirector, Chief Executive Officer
    SERASERA PROGNOSTICS, INC.
    Open-market sale
    		SELL$14K
    7,022 sh
    		Sep 10, 2026Sep 11, 2026
    traded Sep 10, 2026
    		+1dSEC FORM 4

    Evidence

    32
    AL
    Anderson Dyaarl Lee Jr.Chief Commercial Officer
    SERASERA PROGNOSTICS, INC.
    Open-market sale
    		SELL$3,600
    1,800 sh
    		Sep 10, 2026Sep 11, 2026
    traded Sep 10, 2026
    		+1dSEC FORM 4

    Evidence

    36
    JB
    Jackson BenjaminGeneral Counsel
    SERASERA PROGNOSTICS, INC.
    Open-market sale
    		SELL$4,380
    2,190 sh
    		Sep 10, 2026Sep 11, 2026
    traded Sep 10, 2026
    		+1dSEC FORM 4

    Evidence

    32
    LZ
    Lindgardt ZhenyaDirector, Chief Executive Officer
    SERASERA PROGNOSTICS, INC.
    Open-market sale
    		SELL$40K
    20.1K sh
    		Sep 8, 2026Sep 9, 2026
    traded Sep 8, 2026
    		+1dSEC FORM 4

    Evidence

    9
    GS
    Gleason ScottChief Financial Officer
    SERASERA PROGNOSTICS, INC.
    Grant or award
    		A—
    169.6K sh
    		Aug 31, 2026Sep 1, 2026
    traded Aug 31, 2026
    		+1dSEC FORM 4

    Evidence

    9
    GS
    Gleason ScottChief Financial Officer
    SERASERA PROGNOSTICS, INC.
    Grant or award
    		A—
    117.9K sh
    		Aug 31, 2026Sep 1, 2026
    traded Aug 31, 2026
    		+1dSEC FORM 4

    Evidence

    36
    ID
    Inglis Tiffany Eul DavisChief Medical Officer
    SERASERA PROGNOSTICS, INC.
    Open-market sale
    		SELL$728
    362 sh
    		Jun 11, 2026Jun 15, 2026
    traded Jun 11, 2026
    		+4dSEC FORM 4

    Evidence

    32
    LZ
    Lindgardt ZhenyaDirector, Chief Executive Officer
    SERASERA PROGNOSTICS, INC.
    Open-market sale
    		SELL$14K
    6,990 sh
    		Jun 11, 2026Jun 15, 2026
    traded Jun 11, 2026
    		+4dSEC FORM 4

    Evidence

    32
    AA
    Aerts AustinChief Financial Officer
    SERASERA PROGNOSTICS, INC.
    Open-market sale
    		SELL$4,094
    2,037 sh
    		Jun 11, 2026Jun 15, 2026
    traded Jun 11, 2026
    		+4dSEC FORM 4

    Evidence

    40
    AL
    Anderson Dyaarl Lee Jr.Chief Commercial Officer
    SERASERA PROGNOSTICS, INC.
    Open-market sale
    		SELL$9,525
    4,739 sh
    		Jun 11, 2026Jun 15, 2026
    traded Jun 11, 2026
    		+4dSEC FORM 4

    Evidence

    36
    LZ
    Lindgardt ZhenyaDirector, Chief Executive Officer
    SERASERA PROGNOSTICS, INC.
    Open-market sale
    		SELL$43K
    20.8K sh
    		Jun 9, 2026Jun 10, 2026
    traded Jun 9, 2026
    		+1dSEC FORM 4

    Evidence

    36
    AA
    Aerts AustinChief Financial Officer
    SERASERA PROGNOSTICS, INC.
    Open-market sale
    		SELL$11K
    5,440 sh
    		Jun 9, 2026Jun 10, 2026
    traded Jun 9, 2026
    		+1dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0002072324-26-000002
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    May 29, 2026
    Published
    Jun 1, 2026
    Ingested by INSIDER
    Nov 5, 03:55 UTC
    Last re-read
    Nov 5, 03:55 UTC

    Extracted facts

    Filer
    Anderson Dyaarl Lee Jr.
    Role
    Chief Commercial Officer
    Transaction
    Grant or awardAs filed: “A”
    Asset
    SERA PROGNOSTICS, INC.
    Ticker
    SERA
    Shares
    3,168
    Price per share
    $1.84
    Value
    $5,829
    Execution date (reported)
    May 29, 2026
    Owned after transaction
    82.7K shares
    Days from execution to publication
    3

    Calculation

    Value = shares × reported price per share

    • Shares: 3,168
    • Price: $1.84

    = $5,829

    What this establishes

    Anderson Dyaarl Lee Jr. filed this Form 4 reporting a grant or award of SERA on May 29, 2026. It became public on Jun 1, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Chief Commercial Officer
    Anderson Dyaarl Lee Jr.cik:0002072324
    Issuer
    SERA PROGNOSTICS, INC.cik:0001534969

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.